Cartesian’s $150M financing; Editas Medicine’s money moves
May 26, 2026 11:06 AM EDT
News Briefing
Cartesian secures funding to 'accelerate' launch; Editas sells $125M in stock
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
EU and US advisers split over AstraZeneca breast cancer drug
Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
Immunovant shares surge on arthritis trial data
Five biotech news updates to stay on top of today
